Through the combination, iTernity adds expertise in the highly regulated pharmaceutical vertical, while maintaining its broader focus of being a sector agnostic data management solution provider.
Founded in 2004 and headquartered in Freiburg, Germany, iTernity develops software-defined storage for archiving and backups that ensure long-term data protection and regulatory compliance. Its flagship products, iCAS and iCAS FS, are deployed by over 1,400 international customers across healthcare, automotive, public sector, pharma, and industrial verticals. The company’s partner-led sales model and scalable software architecture have contributed to strong growth and customer retention. The management team from iTernity – Armin Weißer and Tobias Neerfeld – remains committed and will stay onboard for the company’s next growth chapter.
The merger combines biomedion’s expertise in GxP-compliant data archiving with exclusive focus on the pharmaceutical industry with iTernity’s enterprise-grade SDS infrastructure. biomedion’s flagship platform, Watcher, automates the secure storage of raw laboratory data in highly regulated environments. iTernity’s solutions, including iCAS and ICAS FS, offer scalable, tamper-proof archiving across a wide range of industries. Together, the companies now offer a comprehensive and modern software suite consisting of:
The newly formed group is powered by a team of experienced professionals with deep industry knowledge. Their unified offering strengthens data integrity, supports regulatory compliance, and ensures audit readiness for customers across sectors
This acquisition embodies a strategic milestone towards our ambition of building a leading European software group within data management and archiving solutions.''
Armin Weißer, CEO of iTernity, comments: “Joining forces with biomedion marks an important step in iTernity’s evolution. We share a strong commitment to data integrity and compliance, and together we can deliver broader, more integrated solutions to our customers. This partnership opens new opportunities for innovation, growth, and long-term value for our clients and partners.”
Andreas Hepfner, CEO of biomedion, adds: “We are pleased to collaborate with iTernity in a broader group setting. Their expertise in scalable archiving and data protection complements our strengths in regulated data management. By combining our capabilities, we can offer a more complete platform that meets the increasing demands of compliance, data volume, and operational resilience.”
Founded in 2000 and headquartered in Berlin, Germany, biomedion provides GxP-compliant data management software for the life sciences industry. Its core product, Watcher, enables automated, audit-ready archiving of raw data from lab instruments in line with global regulatory standards. The company serves top pharmaceutical and biosimilar firms, CROs, and biotech’s across Europe and North America.
Founded in 2004 and headquartered in Freiburg, Germany, iTernity develops software-defined storagefor archiving and backup solutions that ensure long-term data protection and regulatory compliance. Its core products, iCAS and iCAS FS, enable tamper-proof, scalable storage of critical business data across sectors such as healthcare, the public sector, and industry. The company supports over 1,400 customers through a strong partner network.
Nothing contained in this Press Release is intended to project, predict, guarantee, or forecast the future performance of any investment. This Press Release is for information purposes only and is not investment advice or an offer to buy or sell any securities or to invest in any funds or other investment vehicles managed by Main Capital Partners or any other person.